SLC38A1 and endometrial cancer: For endometrial cancer, ectopically expressed CENP-A upregulates SLC38A1 (Solute Carrier Family 38 member 1), leading to the enhancement in metabolism reprogramming and glutamine uptake, which subsequently contribute to its aggressiveness and poor prognosis [193].